What the research found

Researchers tested adrenal function in 216 people across three groups: those with normal blood pressure, those with hypertension and obesity, and those with diabetes and overweight/obesity. Using dexamethasone suppression and cosyntropin stimulation tests alongside 24-hour urine cortisol measurement, they identified a pattern of elevated cortisol that wasn't driven by high ACTH—the pituitary hormone that normally signals the adrenal glands to produce cortisol.

Around 7% of the entire cohort showed this ACTH-independent elevation, with prevalence increasing slightly as cardiometabolic burden increased (5.6% in the normotensive group, rising to 11% in those with diabetes and obesity). The key finding: people with this pattern had exaggerated cortisol responses to cosyntropin stimulation—meaning their adrenal tissue itself was more responsive to ACTH signals, even though baseline ACTH levels were suppressed.

Why it matters for you

If you're tracking cortisol via 24-hour urine or midnight salivary samples as a proxy for recovery and metabolic stress, this research suggests the picture may be more nuanced than a simple "high cortisol = overtraining" interpretation. A subset of people—particularly those managing hypertension, obesity, or blood sugar control—may have adrenal tissue that's primed to respond aggressively to stress signals, even when their baseline ACTH isn't elevated.

This could affect how you interpret your own biomarkers. Standard cortisol tests might appear normal at rest, but the adrenal capacity itself may be dysregulated. If you're optimizing training volume, sleep, or stress management and seeing persistent cardiometabolic issues despite reasonable cortisol readings, this hints that adrenal reactivity—not just resting levels—might warrant attention. The mechanism remains unclear, but it's distinct from classic Cushing's syndrome and may be more common than previously recognized.

Caveats

  • Cross-sectional design: The study describes prevalence but cannot establish causation or whether this adrenal pattern drives cardiometabolic risk or results from it
  • Small subgroup sizes: Only 7–16 individuals per group met the ACTH-independent criteria; larger follow-up studies needed
  • Limited clinical correlation: No biomarkers differed between those with and without the pattern (BMI, A1c, blood pressure, renal function were similar), raising questions about clinical significance
  • Mechanistic gaps: The study identifies a biochemical phenotype but doesn't explain why adrenal tissue becomes hypersensitive or whether it's reversible